Data Science in the News

Machine learning tool fills in the blanks for satellite light curves

When viewed from Earth, objects in space are seen at a specific brightness, called apparent magnitude. Over time, ground-based telescopes can track a specific object’s change in brightness. This time-dependent magnitude variation is known as an object’s light curve, and can allow astronomers to infer the object’s size, shape, material, location, and more. Monitoring the light curve of...

Consulting service infuses Lab projects with data science expertise

A key advantage of LLNL’s culture of multidisciplinary teamwork is that domain scientists don’t need to be experts in everything. Physicists, chemists, biologists, materials engineers, climate scientists, computer scientists, and other researchers regularly work alongside specialists in other fields to tackle challenging problems. The rise of Big Data across the Lab has led to a demand for...

Understanding the universe with applied statistics (VIDEO)

In a new video posted to the Lab’s YouTube channel, statistician Amanda Muyskens describes MuyGPs, her team’s innovative and computationally efficient Gaussian Process hyperparameter estimation method for large data. The method has been applied to space-based image classification and released for open-source use in the Python package MuyGPyS. MuyGPs will help astronomers and astrophysicists...

Panel discussion spotlights COVID-19 R&D

The DSI’s career panel series continued on June 28 to highlight some of LLNL’s COVID-19 research projects. Three data scientists—Emilia Grzesiak, Derek Jones, and Priyadip Ray—joined moderator and data scientist Stewart He to talk about their work in drug screening, protein–drug compounds, antibody–antigen sequence analysis, and risk factor identification. He, who earned a PhD in Computer...

UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19

Students from the University of California, Merced worked with mentors at LLNL to identify drug compounds that could be used to treat COVID-19 during a two-week Data Science Challenge (DSC) that concluded on June 6. For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced...

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

Kevin McLoughlin applies computational biology to complex problems

Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Machine learning model finds COVID-19 risks for cancer patients

A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

LLNL team models COVID-19 disease progression and identifies risk factors

An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

Building confidence in materials modeling using statistics

LLNL statisticians, computational modelers, and materials scientists have been developing a statistical framework for researchers to better assess the relationship between model uncertainties and experimental data. The Livermore-developed statistical framework is intended to assess sources of uncertainty in strength model input, recommend new experiments to reduce those sources of uncertainty...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Summer scholar develops data-driven approaches to key NIF diagnostics

Su-Ann Chong's summer project, “A Data-Driven Approach Towards NIF Neutron Time-of-Flight Diagnostics Using Machine Learning and Bayesian Inference,” is aimed at presenting a different take on nToF diagnostics. Neutron time-of-flight diagnostics are an essential tool to diagnose the implosion dynamics of inertial confinement fusion experiments at NIF, the world’s largest and most energetic...

Tackling the COVID-19 pandemic

To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

COVID-19 HPC Consortium reflects on past year

COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Ana Kupresanin featured in FOE alumni spotlight

LLNL's Ana Kupresanin, deputy director of the Center for Applied Scientific Computing and member of the Data Science Institute council, was recently featured in a Frontiers of Engineering (FOE) alumni spotlight. Kupresanin develops statistical and machine learning models that incorporate real-world variability and probabilistic behavior to quantify uncertainties in engineering and physics...

Model for COVID-19 drug discovery a Gordon Bell finalist

A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

Advancing healthcare with data science (VIDEO)

This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...

Modeling neuronal cultures on 'brain-on-a-chip' devices

For the past several years, LLNL scientists and engineers have made significant progress in development of a three-dimensional “brain-on-a-chip” device capable of recording neural activity of human brain cell cultures grown outside the body. The team has developed a statistical model for analyzing the structures of neuronal networks that form among brain cells seeded on in vitro brain-on-a...

COVID-19 research goes public through new portal

A new online data portal is making available to the public a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of small molecules and designed antibodies for interactions with the SARS-CoV-2 virus for drug design purposes. The portal houses a wealth of data LLNL scientists have gathered from...